Wednesday, August 26, 2026

Tech Sector

3 articles

Alphabet Raises 2026 Capex Guidance as Cloud Capacity Stays Supply-Constrained

Alphabet Raises 2026 Capex Guidance as Cloud Capacity Stays Supply-Constrained

Alphabet lifted its 2026 capital expenditure outlook after CFO Anat Ashkenazi said Google Cloud remains supply-constrained for a multiple consecutive quarters. The move puts Alphabet inside a roughly $650 billion 2026 spending envelope shared by four AI hyperscalers, raising the stakes for investors weighing capex against returns.

LM Salvado
TSMC Lifts 2026 Capex Target After Record Q2, Boosting Equipment Makers

TSMC Lifts 2026 Capex Target After Record Q2, Boosting Equipment Makers

TSMC raised its 2026 capital spending target on July 16 after posting record second-quarter results, signaling sustained AI chip demand. Semiconductor equipment supplier Applied Materials is already up 121% year-to-date, and analysts are watching whether ASML and Lam Research follow the same trajectory.

LM Salvado
AI Cloud Providers Pivot to Self-Built Data Centers as Infrastructure Bottlenecks Replace Chip Shortages

AI Cloud Providers Pivot to Self-Built Data Centers as Infrastructure Bottlenecks Replace Chip Shortages

CoreWeave and other specialized AI cloud providers are developing in-house data center construction capabilities as powered shell infrastructure has become the primary deployment constraint, not chip availability or power access. The shift marks a vertical integration push aimed at cutting deployment delays, with CoreWeave expecting to resolve the majority of current backlogs by Q1 2026.

ViaNews Editorial Team (Markets)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com